48,830
edits
(→IHC) |
|||
Line 76: | Line 76: | ||
*CD38 -ve/+ve. | *CD38 -ve/+ve. | ||
**CD38 -ve suggests a good prognosis.<ref name=pmid12676780>{{cite journal |author=Guarini A, Gaidano G, Mauro FR, ''et al.'' |title=Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features |journal=Blood |volume=102 |issue=3 |pages=1035–41 |year=2003 |month=August |pmid=12676780 |doi=10.1182/blood-2002-12-3639 |url=}}</ref> | **CD38 -ve suggests a good prognosis.<ref name=pmid12676780>{{cite journal |author=Guarini A, Gaidano G, Mauro FR, ''et al.'' |title=Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features |journal=Blood |volume=102 |issue=3 |pages=1035–41 |year=2003 |month=August |pmid=12676780 |doi=10.1182/blood-2002-12-3639 |url=}}</ref> | ||
A panel - based on ''Rizzo and Nassiri'':<ref><ref name=lymphoma>{{Cite journal | last1 = Rizzo | first1 = K. | last2 = Nassiri| first2 = M. | title = Diagnostic Workup of Small B Cell Lymphomas: A Laboratory Perspective. | journal = Lymphoma | volume = | issue = | pages = | month = | year = 2012 | doi =doi:10.1155/2012/346084| PMID = }}</ref> | |||
*CD20, CD5, CD21, CD23, CD3, CD43, cyclin D1. | |||
==Molecular== | ==Molecular== |
edits